By Lene Jorgensen, Hanne Morck Nielson
Advances in biotechnology have supplied scientists with more and more biopharmaceuticals akin to novel peptide and protein medicines in addition to nucleic acid dependent medicinal drugs for gene remedy. in spite of the fact that, winning supply of those biopharmaceuticals is a huge problem simply because their molecular houses bring about bad actual and chemical balance within the physique and constrained membrane permeability. hence researchers are constructing a variety of new supply applied sciences and fabrics to permit those new medicinal drugs to be brought intact to their goal websites.
Delivery applied sciences for Biopharmaceuticals describes suggestions to beat the most boundaries for winning supply of healing peptides, proteins, and nucleic acid-based medications or vaccines relating to the positioning of management and the objective website. a few of the techniques defined are mentioned in formulations in present medical trials in addition to in advertised items. Contents comprise:
- challenges in supply of biopharmaceuticals
- novel formula ways for peptide and protein injectables
- non-viral chemical vectors and viral expertise for supply of nucleic acid established medicinal drugs
- immune reaction, adjuvants and supply structures for vaccines
- several examples of supply structures for different biopharmaceuticals
- a severe evaluate of supply applied sciences for biopharmaceuticals
Delivery applied sciences for Biopharmaceuticals is a necessary single-volume advent to the applied sciences utilized by researchers to make sure effective supply of this intriguing new classification of substances. it will likely be of price to researchers and scholars operating in drug supply, formula, biopharmaceuticals, medicinal chemistry, and new fabrics development.Content:
Chapter 1 demanding situations in supply of Biopharmaceuticals; the necessity for complicated supply structures (pages 1–8): Hanne Morck Nielsen and Lene Jorgensen
Chapter 2 Novel formula methods for Peptide and Protein Injectables (pages 9–28): Mingshi Yang and Sven Frokjaer
Chapter three Novel Non?Injectable formula techniques of Peptides and Proteins (pages 29–67): Shirui Mao, Dongmei Cun and Yoshiaki Kawashima
Chapter four Chemical Vectors for supply of Nucleic Acid?Based medicines (pages 69–92): Elizabeth A. Vasievich and Leaf Huang
Chapter five Viral know-how for supply of Nucleic Acids (pages 93–112): Shervin Bahrami and Finn Skou Pedersen
Chapter 6 The Innate Immune Responses, Adjuvants and supply platforms (pages 113–127): S. Moein Moghimi
Chapter 7 Lipid Nanoparticle?Based platforms for supply of Biomacromolecule Therapeutics (pages 129–148): Susana Martins, Domingos C. Ferreira and Eliana B. Souto
Chapter eight Dendrimers in supply of Biopharmaceuticals (pages 149–168): Chandan Thomas and Fakhrul Ahsan
Chapter nine amendment of Peptides and Proteins (pages 169–191): Susanne Hostrup, Kasper Huus and Henrik Parshad
Chapter 10 Nanocarriers for the supply of Peptides and Proteins (pages 193–205): Kenneth Lundstrom
Chapter eleven Polymer?Based supply platforms for Oral supply of Peptides and Proteins (pages 207–226): Bruno Sarmento, Domingos Ferreira and Teofilo Vasconcelos
Chapter 12 complicated Pulmonary supply of Peptides or Proteins utilizing Polymeric debris (pages 227–244): Yu Seok Youn, Kang Choon Lee, You Han Bae, Kun Na and Eun Seong Lee
Chapter thirteen Polymer Microparticles for Nucleic Acid supply (pages 245–267): Tim Pearce, Jared Hierman and Chun Wang
Chapter 14 Pulmonary supply of Small Interfering RNA for Novel Therapeutics (pages 269–289): Qing Ge, David Evans, John J. Xu, Harry H. Yang and Patrick Y. Lu
Chapter 15 Lipid?Based Formulations for siRNA supply (pages 291–304): Camilla Foged, Pieter Vader and Raymond M. Schiffelers
Chapter sixteen mobile Bioavailability of Peptide Nucleic Acids (PNAs) Conjugated to cellphone Penetrating Peptides (pages 305–338): Takehiko Shiraishi and Peter E. Nielsen
Chapter 17 DEAE?dextran?MMA Graft Copolymer for Non?Viral supply of DNA (pages 339–355): Yasuhiko Onishi, Yuki Eshita and Masaaki Mizuno
Chapter 18 Liposomes in Adjuvant structures for Parenteral supply of Vaccines (pages 357–376): Dennis Christensen, Karen Korsholm, Grith Kroyer wooden, Afzal Mohammed, Vincent Bramwell, Peter Andersen, Else Marie Agger and Yvonne Perrie
Chapter 19 Influenza Virosomes as supply structures for Antigens (pages 377–393): Mario Amacker, Stefan Moese, Andreas R. Kammer, Ari Helenius and Rinaldo Zurbriggen
Chapter 20 GRAZAX®: An Oromucosal Vaccine for Treating Grass Pollen hypersensitivity with Immunotherapy (pages 395–404): Annette Rommelmayer Lundegaard, Lise Lund and Jorgen Nedergaard Larsen
Chapter 21 supply applied sciences for Biopharmaceuticals: A severe evaluation (pages 405–412): Marco van de Weert
Read or Download Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines PDF
Best organic books
A winery Odyssey is an interesting saga of wine—the trip from vine to bottle—that takes the reader on a travelogue of the numerous risks that lie alongside the best way. John Kiger tracks the nefarious denizens of the winery global: the host of bugs, fungi, micro organism, and viruses, besides the feathered and hairy critters, that lurk in vineyards.
Roswell Park melanoma Institute, Buffalo, ny. finished, present precis of glycoconjugate biochemistry for researchers and complex scholars. 29 individuals. DNLM: Glycoconjugates.
This booklet makes a speciality of the drug discovery and improvement purposes of transition steel catalyzed tactics, that can successfully create preclinical and scientific drug applicants in addition to advertised drugs. The authors pay specific cognizance to the demanding situations of transitioning academically-developed reactions into scalable business approaches.
Reconquest of biodiversity; remediation of degraded and anthropic parts, prevention of environmental healthiness hazards; eco-innovation; eco-friendly . .. the present French objectives are heavily concerning an interdisciplinary method of medical ecology, all of which perform the anticipated commercial renewal.
- Fundamentals of organic chemistry
- Organozinc Reagents: A Practical Approach
- Advances in Organic Geochemistry 1968. Proceedings of the 4th International Meeting on Organic Geochemistry, Held in Amsterdam, September 16–18, 1968
- R.B. Woodward Remembered. A Collection of Papers in Honour of Robert Burns Woodward 1917–1979
Extra info for Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines
Eur. J. , 456, 149–158. 54. W. et al. (2003) N-beta-albumin fusion protein that displays improved pharmacokinetic and pharmacodynamic properties in nonhuman primates. J. , 23, 25–36. 55. L. et al. (2005) Development of a long-acting insulin analog using albumin fusion technology. Diabetes, 54, 251–258. 56. P. (2007) Modified transferrin fusion proteins. United States Patent, 7176278. 57. T. and Celebi, N. (2007) Controlled delivery of peptides and proteins. Curr. Pharm. Design, 13, 99–117. 58. R.
And Adam, A. (2002) Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials, 23, 2717–2722. 100. , Daugherty, A. and Mrsny, R. (2001) Emerging protein delivery methods. Curr. Opin. , 12, 212–219. 101. M. N. (1996) Goserelin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders. Drugs, 51, 319–346. 102. W. and Civitelli, K. (2001) Managing advanced prostate cancer with Viadur (leuprolide acetate implant).
2008) Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J. Pharm. , 97, 2395–2404. 88. F. J. (1993) Development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Crit. Rev. Ther. , 10, 307–377. 89. , Stevenson, M. et al. (2000) DepToam™ technology: a vehicle for controlled delivery of protein and peptide drugs. J. Control. Release, 64, 155–166. 90. B. (2001) Clinical application of a novel sustained-release injectable drug delivery system: DepoFoam™ technology.